12/14/09Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R)
11/23/09Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter
Here you will find a summary of Transcept Pharmaceuticals's latest financial information.
Data is currently unavailable.
